Genomind 360
Learning Center

Healthcare providers

Pharmacogenetic Considerations for Treatment of the Geriatric Population

Genomind Educational Webinar event card Pharmacogenetic Considerations for Treatment of the Geriatric Population Daniel Dows PharmD

Join Genomind’s Vice President of Medical Affairs, Dr. Daniel Dowd, for a clinical presentation. Dr. Dowd will discuss pharmacogenetic considerations that can be applied in the treatment of geriatric and comorbid patients. He will also demonstrate how GenMed✓ Pro, Genomind’s precision gene-drug interaction software, can be utilized in the assessment of treatment options for this population.

Filmed June 17th, 2021

Are You Ready to Upgrade Your Practice with Genomind?

Genomind’s pharmacogenetic testing is the most advanced and comprehensive mental health pharmacogenetic test available. Get access to 24 genes related to mental health, 130+ medications, 10+ conditions, state-of-the-art tools, and 360 degrees of support today!

Continued education to evolve your practice.

Free educational content and resources direct from the Genomind team.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.